The role of microRNA-133 in cardiac hypertrophy uncovered.
Abdellatif
Maha
M
D000818:Animals; D006332:Cardiomegaly / Q000139:chemically induced / Q000235:genetics / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D002316:Cardiotonic Agents / Q000009:adverse effects / Q000494:pharmacology; D003971:Diastole; D004562:Electrocardiography; D005355:Fibrosis; D005786:Gene Expression Regulation / Q000235:genetics; D006352:Heart Ventricles / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D007545:Isoproterenol / Q000009:adverse effects / Q000494:pharmacology; D051605:Kv Channel-Interacting Proteins / Q000096:biosynthesis / Q000235:genetics; D051379:Mice; D008822:Mice, Transgenic; D035683:MicroRNAs / Q000096:biosynthesis* / Q000235:genetics; D032383:Myocytes, Cardiac / Q000378:metabolism* / Q000473:pathology; D018995:Myosin Heavy Chains / Q000235:genetics; D011401:Promoter Regions, Genetic / Q000235:genetics
D002316:Cardiotonic Agents; C496755:Kcnip2 protein, mouse; D051605:Kv Channel-Interacting Proteins; D035683:MicroRNAs; C517732:Mirn133 microRNA, mouse; D018995:Myosin Heavy Chains; D007545:Isoproterenol